Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EC in Japan

This article was originally published in The Tan Sheet

Executive Summary

Tokyo, Japan-based firm Sosei Group announces Nov. 17 the commencement of a Phase I clinical trial for the emergency contraceptive pill SOH-075 (NorLevo). The clinical trial is a randomized, double-blind, placebo-controlled study on a total of 33 Japanese adult female volunteers in three cohorts at a single study center. This will be the first emergency contraceptive pill introduced in Japan, the company says. The firm says it acquired the exclusive distribution rights to the product in Japan from Laboratoire HRA Pharma. In the U.S., Barr's emergency contraceptive pill Plan B became available for age-restricted sale behind pharmacy counters this month (1"The Tan Sheet" Nov. 13, 2006, p. 8)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel